SEC Comment Letter 0000000000-23-010347 to VACCINEX, INC. (VCNX) (CIK 0001205922) (VCNX)
VACCINEX, INC. (VCNX) (CIK 0001205922)
Date: Sept. 20, 2023 · CIK: 0001205922 · Accession: 0000000000-23-010347
AI Filing Summary & Sentiment
File numbers found in text: 333-274520
Letter
United States securities and exchange commission logo September 20, 2023 Maurice Zauderer, Ph.D. Chief Executive Officer Vaccinex, Inc. 1895 Mount Hope Avenue Rochester, NY 14620 Re:Vaccinex, Inc. Registration Statement on Form S-1 Filed September 14, 2023 File No. 333-274520 Dear Maurice Zauderer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: William Intner, Esq.
Show Raw Text
United States securities and exchange commission logo
September 20, 2023
Maurice Zauderer, Ph.D.
Chief Executive Officer
Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester, NY 14620
Re:Vaccinex, Inc.
Registration Statement on Form S-1
Filed September 14, 2023
File No. 333-274520
Dear Maurice Zauderer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: William Intner, Esq.